Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
CTVA Quote, Financials, Valuation and Earnings
Last price:
$73.22
Seasonality move
:
5.74%
Day range:
$71.78 - $73.04
52-week range:
$50.30 - $77.41
Dividend yield:
0.93%
P/E ratio:
44.50x
P/S ratio:
3.00x
P/B ratio:
2.05x
Volume:
4M
Avg. volume:
4.4M
1-year change:
34.65%
Market cap:
$49.8B
Revenue:
$16.9B
EPS (TTM):
$1.64
Earnings Data
Next earnings date for CTVA
Aug 06
2025
Most recent earnings per share
$0.95
Beat by $0.07
(May 7/2025)
Consensus Estimate
$0.88
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CTVA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $2.5B | -- | -- | -$0.37 | -- |
| 08/06/2025 | Q2 | $6.3B | -- | -- | $1.88 | -- |
| 05/07/2025 | Q1 | $4.5B | $4.4B | $0.95 | $0.88 | $0.07 |
| 02/05/2025 | Q4 | $4B | $4B | -$0.06 | $0.31 | -$0.37 |
| 11/06/2024 | Q3 | $2.7B | $2.3B | -$0.76 | -$0.30 | -$0.46 |
| 07/31/2024 | Q2 | $6.2B | $6.1B | $1.51 | $1.72 | -$0.21 |
| 05/01/2024 | Q1 | $4.6B | $4.5B | $0.60 | $0.83 | -$0.23 |
| 01/31/2024 | Q4 | $3.6B | $3.7B | -$0.36 | $0.06 | -$0.42 |
| 11/08/2023 | Q3 | -- | -- | -$0.45 | -$0.26 | -$0.19 |
| 08/03/2023 | Q2 | -- | -- | $1.00 | $1.58 | -$0.58 |
| 05/03/2023 | Q1 | -- | -- | $0.83 | $0.93 | -$0.10 |
| 02/01/2023 | Q4 | -- | -- | -$0.08 | $0.06 | -$0.14 |
| 11/03/2022 | Q3 | -- | -- | -$0.46 | -$0.22 | -$0.24 |
| 08/04/2022 | Q2 | -- | -- | $1.33 | $1.46 | -$0.13 |
| 05/04/2022 | Q1 | -- | -- | $0.78 | $0.81 | -$0.03 |
| 02/02/2022 | Q4 | -- | -- | $0.22 | $0.09 | $0.13 |
| 11/04/2021 | Q3 | -- | -- | $0.04 | -$0.31 | $0.35 |
| 08/05/2021 | Q2 | -- | -- | $1.31 | $1.27 | $0.04 |
| 05/04/2021 | Q1 | -- | -- | $0.80 | $0.65 | $0.15 |
| 02/04/2021 | Q4 | -- | -- | $0.05 | -$0.04 | $0.09 |
| 11/06/2020 | Q3 | -- | -- | -$0.52 | -$0.42 | -$0.10 |
| 07/30/2020 | Q2 | -- | -- | $1.01 | $1.24 | -$0.23 |
| 05/07/2020 | Q1 | -- | -- | $0.36 | $0.39 | -$0.03 |
| 01/30/2020 | Q4 | -- | -- | -$0.03 | -$0.12 | $0.09 |
| 10/31/2019 | Q3 | -- | -- | -$0.66 | -$0.45 | -$0.21 |
| 08/01/2019 | Q2 | -- | -- | -$0.81 | $1.02 | -$1.83 |
| 03/31/2019 | Q1 | -- | -- | $0.22 | $0.44 | -$0.22 |
| 12/31/2018 | Q4 | -- | -- | -$0.71 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$6.83 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.93 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.29 | -- | -- |
Corteva Earnings Questions
-
How Much did Corteva Generate in Revenue Last Quarter?
Corteva reported $4.4B worth of top line sales in its most recent quarter.
-
Did Corteva Beat Earnings Last Quarter?
Corteva announced earnings per share of $0.95 which represents a beat of analyst forecast a $0.88 per share.
-
Is Corteva Profitable?
Corteva reported $2.1B that represents $3.02 per share over the last quarter.
-
What is the Analyst Consensus for Corteva EPS Next Year?
Corteva's earnings are forecast to grow from $1.30 per share to $2.55 per share next year representing an increase of 130.41%.
-
When is Corteva's Earnings Date?
Corteva's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
